Ignite Creation Date:
2024-05-05 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 9:58 AM
Study NCT ID:
NCT00795158
Status:
COMPLETED
Last Update Posted:
2022-02-17
First Post:
2008-11-20
Brief Title:
How Desloratadine Clarinex Aerius Affects Quality of Life in Patients With Chronic Idiopathic Urticaria Have Had Hives for 6 Weeks or LongerStudy P02988
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
An Open-Label Study of the Effects of Desloratadine Treatment on the Quality of Life of Patients With Chronic Urticaria
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to determine the effect of desloratadine treatment on quality of life daytime functioning quality of sleep symptoms and disease severity in patients who had hives for 6 weeks or longer Patients took desloratadine for 1 month Once a week patients filled out a questionnaire to tell how their hives affected their lives This questionnaire is called the Dermatology Life Quality Index or DLQI They also filled out a diary every day to tell how much itching they had how many hives they had and how their hives had affected their sleep or daily activities The patients and doctors rated the patients overall condition and how much relief patients got from treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None